Dr. Dr Suomi Fouraschen
Claim this profileUniversity Medical Center Groningen
Studies Blood Loss
Studies Liver Disease
1 reported clinical trial
2 drugs studied
More about Dr Suomi Fouraschen
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Dr Suomi Fouraschen has experience with
- GATT-Patch
- TachoSil
Breakdown of trials Dr Suomi Fouraschen has run
Liver Dysfunction
Surgical Bleeding
Intraoperative Blood Loss
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dr Suomi Fouraschen specialize in?
Dr Suomi Fouraschen focuses on Blood Loss and Liver Disease. In particular, much of their work with Blood Loss has involved treating patients, or patients who are undergoing treatment.
Is Dr Suomi Fouraschen currently recruiting for clinical trials?
No, Dr Suomi Fouraschen is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Dr Suomi Fouraschen has studied deeply?
Yes, Dr Suomi Fouraschen has studied treatments such as GATT-Patch, TachoSil.
What is the best way to schedule an appointment with Dr Suomi Fouraschen?
Apply for one of the trials that Dr Suomi Fouraschen is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.